10th International Inter University Scientific Meeting
Academy of Studenica
PERSPECTIVES IN MELANOMA MANAGEMENT
& NANOTECHNOLOGY IN BIOMEDICINE
Organizers: Institute of Oncology Sremska Kamenica; Union of Cancer Prevention
Societies of Vojvodina, Novi Sad; Clinic of Oncology, Nis; Institute for Oncology and Radiology of Serbia, Belgrade Center for Bioengineering, Faculty of Mechanical Engineering, University of Belgrade
President: Vladimir Baltic Vice-presidents: Zlata Janjic, Radan Dzodic, Borislava Nikolin; Djuro Koruga
ISSN 1450-708

Content
7 /2004
 
PREGNANCY AND MALIGNANT MELANOMA
 Potić-Zečević N, Stanojević Z, Marković M, Todorovska I, *Stanojević M.
 Clinic of Oncology, Clinical Centre Niš, Niš, Serbia and Montenegro
* Clinic od Dermatovenerology, Clinical Centre Niš, Niš, Serbia and Montenegro
 
  ABSTRACT
Numerous malignant diseases reach their incidence peak in female fertile years. That is the reason why these diseases are the second most common cause of death of women in their generative age. However, neoplastic processes are rarely diagnosed in pregnancy and there are no clear-cut guidelines on whether the pregnancy should be terminated in order that a proper treatment could be applied, or what are the consequences for both the mother and her child if the pregnancy is allowed to continue despite the diagnosis of malignancy. Malignant melanoma is one of the most common tumours diagnosed in pregnancy (8% of all diagnosed neoplasms). Some studies present the data on successfully terminated pregnancies in these women but also point out the risks the fetus is exposed to due to possible application of cytotoxic therapy, as well as the danger of transplacental spread of this process to the placenta and fetus.
  Keywords: Pregnancy, Malignant melanoma, Outcome  
© Academy of Studenica, 2004